Face-to-Face Versus Distance Learning of Basic Suturing Skills

NCT05275829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2022-03-11

No results posted yet for this study

Summary

The main objective of this study is to determine the acceptability and effectiveness of Distance Learning (DL) of basic suturing skills in novice learners.

A prospective randomized controlled trial involving 118 pre-medical and medical students with no previous experience in suturing was conducted. Participants were randomized into two groups for learning simple interrupted suturing: F-F and DL groups (59 students in each group) . Evaluation was conducted by two independent assessors. Agreement between the assessors was calculated, and performance scores of the participants were compared between the two groups.

All the participants demonstrated their ability to place three interrupted sutures, with no significant difference in the performance between the two groups. All the respondents positively rated the teaching sessions, found them useful and enjoyable.

Distance learning of basic suturing is as effective as the face-to-face approach in novice learners

Conditions

  • Educational Problems

Interventions

OTHER

Tele simulation

Interactive tele simulation sessions utilising web-based video-conferencing technology (WebEx platform).

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Ahmad Zaghal, MD, MSc, FACS, FEBPS · American University of Beirut Medical Center ; Department of Surgery

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-04
Primary Completion
2021-05-19
Completion
2021-05-19

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05275829 on ClinicalTrials.gov